MediWound Ltd. - Common Shares (MDWD)

CUSIP: M68830104

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Shares
Shares outstanding
12,838,938
Total 13F shares
7,965,343
Share change
+2,813,274
Total reported value
$42,498,000
Price per share
$5.34
Number of holders
19
Value change
+$14,965,316
Number of buys
10
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP M68830104?
CUSIP M68830104 identifies MDWD - MediWound Ltd. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MDWD - MediWound Ltd. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
17%
2,147,539
$14,603,000 30 Jun 2017
13F
Migdal Insurance & Financial Holdings Ltd.
13F
Company
16%
2,028,112
$13,791,000 30 Jun 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
1.8%
226,000
$1,537,000 30 Jun 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
1.6%
199,900
$1,359,000 30 Jun 2017
13F
Broadfin Capital, LLC
13F
Company
1.4%
174,665
$1,188,000 30 Jun 2017
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
1%
129,085
$878,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.62%
80,100
$545,000 30 Jun 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.51%
65,763
$447,000 30 Jun 2017
13F
OPPENHEIMER & CO INC
13F
Company
0.19%
24,500
$167,000 30 Jun 2017
13F
TFS CAPITAL LLC
13F
Company
0.17%
22,457
$153,000 30 Jun 2017
13F
Na Bokf
13F
Individual
0.15%
19,270
$131,000 30 Jun 2017
13F
Harel Insurance Investments & Financial Services Ltd.
13F
Company
0.11%
14,552
$99,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
10,429
$70,000 30 Jun 2017
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
2,467
$17,000 30 Jun 2017
13F
Creative Planning
13F
Company
0.02%
2,250
$15,000 30 Jun 2017
13F
FNY Partners Fund LP
13F
Company
0.01%
1,700
$11,000 30 Jun 2017
13F
UBS Group AG
13F
Company
0.01%
1,505
$11,000 30 Jun 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
1,000
$7,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.01%
1,000
$7,000 30 Jun 2017
13F

Institutional Holders of MediWound Ltd. - Common Shares (MDWD) as of Q3 2017

As of 30 Sep 2017, MediWound Ltd. - Common Shares (MDWD) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,965,343 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Migdal Insurance & Financial Holdings Ltd., Broadfin Capital, LLC, Alyeska Investment Group, L.P., Nationwide Fund Advisors, BAKER BROS. ADVISORS LP, UNITED SERVICES AUTOMOBILE ASSOCIATION, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, RENAISSANCE TECHNOLOGIES LLC, and WELLS FARGO & COMPANY/MN. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
19
Q3 2017 holders
19
Holder diff
0
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .